|
US 11,939,366 B2 |
|
| Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers |
| Andrea Mahr, Tuebingen (DE); Toni Weinschenk, Aichwald (DE); Colette Song, Ostfildern (DE); Oliver Schoor, Tuebingen (DE); Jens Fritsche, Dusslingen (DE); and Harpreet Singh, Munich (DE) |
| Assigned to IMMATICS BIOTECHNOLOGIES GMBH, Tuebingen (DE) |
| Filed by Immatics Biotechnologies GmbH, Tuebingen (DE) |
| Filed on May 7, 2021, as Appl. No. 17/314,688. |
| Application 17/314,688 is a continuation of application No. 17/068,980, filed on Oct. 13, 2020, abandoned. |
| Application 17/068,980 is a continuation of application No. 16/887,994, filed on May 29, 2020, granted, now 10,829,537, issued on Nov. 10, 2020. |
| Application 16/887,994 is a continuation of application No. 16/778,915, filed on Jan. 31, 2020, granted, now 10,703,795, issued on Jul. 7, 2020. |
| Application 16/778,915 is a continuation of application No. 16/582,046, filed on Sep. 25, 2019, granted, now 10,626,162, issued on Apr. 21, 2020. |
| Application 16/582,046 is a continuation of application No. 16/413,192, filed on May 15, 2019, granted, now 10,487,132, issued on Nov. 26, 2019. |
| Application 16/413,192 is a continuation of application No. 16/281,155, filed on Feb. 21, 2019, granted, now 10,364,282, issued on Jul. 30, 2019. |
| Application 16/281,155 is a continuation of application No. 16/137,489, filed on Sep. 20, 2018, granted, now 10,273,282, issued on Apr. 30, 2019. |
| Application 16/137,489 is a continuation of application No. 15/965,305, filed on Apr. 27, 2018, granted, now 10,294,288, issued on May 21, 2019. |
| Application 15/965,305 is a continuation of application No. 15/202,388, filed on Jul. 5, 2016, granted, now 10,011,645, issued on Jul. 3, 2018. |
| Claims priority of provisional application 62/188,870, filed on Jul. 6, 2015. |
| Claims priority of application No. 1511792 (GB), filed on Jul. 6, 2015. |
| Prior Publication US 2021/0277088 A1, Sep. 9, 2021 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07K 14/00 (2006.01); A61K 35/17 (2015.01); A61K 39/00 (2006.01); C07K 14/47 (2006.01); C07K 14/635 (2006.01); C07K 14/725 (2006.01); C07K 14/74 (2006.01); C07K 16/28 (2006.01); C12N 5/0783 (2010.01); C12Q 1/6886 (2018.01); G01N 33/574 (2006.01); A61K 38/00 (2006.01) |